{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T07:30:23Z","timestamp":1785655823662,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":908,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.14283\/jpad.2021.67","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T11:46:28Z","timestamp":1642160788000},"page":"338-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia"],"prefix":"10.1016","volume":"9","author":[{"given":"B.","family":"Souchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Audrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Orefice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Potier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Billard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Braudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.14283\/jpad.2021.67_bib1","first-page":"171","article-title":"Natural history of Alzheimer's disease","volume":"13","author":"Honig","year":"2001","journal-title":"Aging (Milano)"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer's disease","volume":"77","author":"Perl","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"10.14283\/jpad.2021.67_bib3","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.14283\/jpad.2021.67_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00401-018-1918-8","article-title":"Questions concerning the role of amyloid-beta in the definition, aetiology and diagnosis of Alzheimer's disease","volume":"136","author":"Morris","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.14283\/jpad.2021.67_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05116","article-title":"Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains","volume":"4","author":"Bushman","year":"2015","journal-title":"Elife"},{"issue":"7733","key":"10.14283\/jpad.2021.67_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-018-0718-6","article-title":"Somatic APP gene recombination in Alzheimer's disease and normal neurons","volume":"563","author":"Lee","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.14283\/jpad.2021.67_bib8","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The Infectious Etiology of Alzheimer's Disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"10.14283\/jpad.2021.67_bib9","doi-asserted-by":"crossref","first-page":"e0217026","DOI":"10.1371\/journal.pone.0217026","article-title":"Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of beta-amyloid peptide and tau","volume":"14","author":"Lafirdeen","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.14283\/jpad.2021.67_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","article-title":"Mild cognitive impairment: a concept in evolution","volume":"275","author":"Petersen","year":"2014","journal-title":"J Intern Med"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib12","first-page":"e12026","article-title":"Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging Initiative","volume":"12","author":"Allegri","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"10.14283\/jpad.2021.67_bib13","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2021.67_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.trci.2016.07.001","article-title":"Alzheimer's drug-development pipeline: 2016","volume":"2","author":"Cummings","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib15","doi-asserted-by":"crossref","first-page":"e12179","DOI":"10.1002\/trc2.12179","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"issue":"11","key":"10.14283\/jpad.2021.67_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115549","article-title":"Alzheimer's Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment","volume":"22","author":"Nakai","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7715","key":"10.14283\/jpad.2021.67_bib17","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/d41586-018-05722-9","article-title":"The search for better animal models of Alzheimer's disease","volume":"559","author":"King","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0312-8","article-title":"Alzheimer disease models and human neuropathology: similarities and differences","volume":"115","author":"Duyckaerts","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13024-020-00412-5","article-title":"A novel systems biology approach to evaluate mouse models of late-onset Alzheimer's disease","volume":"15","author":"Preuss","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"11","key":"10.14283\/jpad.2021.67_bib20","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1093\/cercor\/bhx260","article-title":"betaAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease","volume":"28","author":"Audrain","year":"2018","journal-title":"Cereb Cortex"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-150979","article-title":"Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze","volume":"54","author":"Li","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"228","key":"10.14283\/jpad.2021.67_bib22","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.14283\/jpad.2021.67_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/153331750502000206","article-title":"Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias","volume":"20","author":"Molinuevo","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"4","key":"10.14283\/jpad.2021.67_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-0186(95)00097-6","article-title":"CaM kinase II in long-term potentiation","volume":"28","author":"Fukunaga","year":"1996","journal-title":"Neurochem Int"},{"issue":"5352","key":"10.14283\/jpad.2021.67_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1126\/science.279.5352.870","article-title":"Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning","volume":"279","author":"Giese","year":"1998","journal-title":"Science"},{"issue":"24","key":"10.14283\/jpad.2021.67_bib26","doi-asserted-by":"crossref","first-page":"11175","DOI":"10.1073\/pnas.92.24.11175","article-title":"Calcium\/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism","volume":"92","author":"Lledo","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.14283\/jpad.2021.67_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/NDT.S4048","article-title":"Update on the use of memantine in Alzheimer's disease","volume":"5","author":"van Marum","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.14283\/jpad.2021.67_bib28","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","article-title":"The chemical biology of clinically tolerated NMDA receptor antagonists","volume":"97","author":"Chen","year":"2006","journal-title":"J Neurochem"},{"issue":"2\u20133","key":"10.14283\/jpad.2021.67_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03033787","article-title":"Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease\u2014a unified glutamatergic hypothesis on the mechanism of action","volume":"2","author":"Danysz","year":"2000","journal-title":"Neurotox Res"},{"issue":"23","key":"10.14283\/jpad.2021.67_bib30","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1016\/0006-2952(82)90295-7","article-title":"Studies on the mechanism of phospholipid storage induced by amantadine and chloroquine in Madin Darby canine kidney cells","volume":"31","author":"Hostetler","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.14283\/jpad.2021.67_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1471-4159.2011.07447.x","article-title":"Dysregulated phosphorylation of Ca(2+) \/calmodulin-dependent protein kinase II-alpha in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease","volume":"119","author":"Reese","year":"2011","journal-title":"J Neurochem"},{"issue":"2","key":"10.14283\/jpad.2021.67_bib32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am J Pathol"},{"issue":"2","key":"10.14283\/jpad.2021.67_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","article-title":"Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease","volume":"311","author":"Minkeviciene","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.14283\/jpad.2021.67_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12035-020-02120-z","article-title":"Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer's Disease","volume":"58","author":"Stazi","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.14283\/jpad.2021.67_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00401-013-1129-2","article-title":"N-truncated amyloid beta (Abeta) 4\u201342 forms stable aggregates and induces acute and long-lasting behavioral deficits","volume":"126","author":"Bouter","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.14283\/jpad.2021.67_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:44:15Z","timestamp":1736469855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724003492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2274580724003492"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2021.67","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2021.67","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}